OTC · Biotechnology

ChitogenX Inc. (CHNXF) Stock

$0.01 +0.00% OTC: CHNXF Healthcare

ChitogenX Inc. is a biologics firm focused on orthopedic and sports medicine, committing its efforts to pioneering novel soft tissue repair technologies.

Valuation

MetricValue
Price$0.01
Market Cap$627628
P/E Ratio-0.23
P/B Ratio-0.06
P/S Ratio0.00
EPS (TTM)$-0.02
52-Week High$0.02
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE19.40%
ROA-291.01%
ROCE100.04%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.63
Current Ratio0.07

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-2.0M$-3.0M$-4.0M$-5.0M$-3.0M
Net Profit$-2.0M$-4.0M$-5.0M$-6.0M$-2.0M
EPS$-0.10$-0.13$-0.14$-0.13$-0.02
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$1.0M$3.0M$1.0M$1.0M$1.0M
Total Liabilities$4.0M$5.0M$8.0M$11.0M$7.0M
Cash$0$2.0M$0$0$0
Borrowings$3.0M$5.0M$6.0M$6.0M$4.0M

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-2.0M$-3.0M$-3.0M$-3.0M$-1.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$1.0M$1.0M
Net Cash Flow$0$2.0M$-2.0M$0$0
Free Cash Flow$-2.0M$-3.0M$-3.0M$-3.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-6.35
FCF Yield-242.75%
Quick Ratio0.07
Interest Coverage-3.25
Return 1Y586.36%
Return 3Y-91.22%
Return 5Y-97.19%

Ownership

Insiders Held0.00%
Institutions Held12.39%
Institutions Float Held12.39%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BSYIBioSyntech, Inc. $0.00 — 0.00 $229033 0.00%
IPIXInnovation Pharmaceuticals Inc. $0.00 — -0.32 $1.04M 0.00%
LFCOFLift & Co. Corp. $0.00 — -0.01 $63446 0.00%
MDINMedGen, Inc. $0.00 — -600.00 $90309 0.00%
NBIONascent Biotech, Inc. $0.00 — -0.04 $103330 0.00%

About ChitogenX Inc.

ChitogenX Inc. is a biologics firm focused on orthopedic and sports medicine, committing its efforts to pioneering novel soft tissue repair technologies. The company's primary objective is to elevate the efficacy of sports medicine surgical procedures through its research and development. Its developmental pipeline includes a range of specialized products: Ortho-R, a specific formulation designed for rotator cuff injuries; Ortho-M, a biopolymer addressing meniscus repair; Ortho-C, another biopolymer for the regeneration of articular cartilage; and Ortho-V, a biopolymer developed to facilitate the healing of osteoarthritis. Additionally, they are advancing ORTHO-T, a biopolymer formulation engineered for tendon healing and regeneration. Previously known as Ortho Regenerative Technologies Inc., the company adopted its current name, ChitogenX Inc., in September of 2022. Established in 2015, ChitogenX maintains its headquarters in Kirkland, Canada.

ChitogenX Inc. is headquartered in CA.

ChitogenX Inc. (CHNXF) stock trades at $0.01 with a market capitalization of $627628. The stock is valued at a price-to-earnings (P/E) ratio of -0.23, price-to-book of -0.06, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades 50.0% below its 52-week high.

On profitability, ChitogenX Inc. generates a return on equity (ROE) of 19.40%, above the typical market average, return on capital employed of 100.04%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.chitogenx.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides